These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 526304)

  • 1. In vitro and in vivo studies with adriamycin liposomes.
    Forssen EA; Tökes ZA
    Biochem Biophys Res Commun; 1979 Dec; 91(4):1295-301. PubMed ID: 526304
    [No Abstract]   [Full Text] [Related]  

  • 2. Two types of adriamycin inhibition of a homologous RNA synthesizing system from L1210 cells.
    Maniglia CA; Wilson RG
    Chem Biol Interact; 1981 Jan; 33(2-3):319-27. PubMed ID: 7460071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin.
    Ohnuma T; Elias F; Holland JF; Henderson E
    Eur J Cancer (1965); 1979 Mar; 15(3):363-71. PubMed ID: 446517
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.
    Gabizon A; Dagan A; Goren D; Barenholz Y; Fuks Z
    Cancer Res; 1982 Nov; 42(11):4734-9. PubMed ID: 7127308
    [No Abstract]   [Full Text] [Related]  

  • 6. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
    Harasym TO; Cullis PR; Bally MB
    Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.
    Cervato G; Viani P; Galatulas I; Bossa R; Cestaro B
    Anticancer Res; 1986; 6(6):1287-90. PubMed ID: 3813484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of adriamycin in overcoming resistance to methotrexate in tissue culture.
    Hill BT; Price LA; Goldies JH
    Eur J Cancer (1965); 1976 Jul; 12(7):541-9. PubMed ID: 986302
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amphotericin B on adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia.
    Ozols RF; Hogan WM; Grotzinger KR; McCoy W; Young RC
    Cancer Res; 1983 Mar; 43(3):959-64. PubMed ID: 6825115
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of adriamycin and adriamycin--DNA complex in L1210 mice and men.
    Staquet M; Rozencweig M; Duarte-Karim M; Kenis Y
    Eur J Cancer (1965); 1977; 13(4-5):433-5. PubMed ID: 872859
    [No Abstract]   [Full Text] [Related]  

  • 13. Liposomal protection of adriamycin-induced cardiotoxicity in mice.
    Rahman A; Kessler A; More N; Sikic B; Rowden G; Woolley P; Schein PS
    Cancer Res; 1980 May; 40(5):1532-7. PubMed ID: 7370991
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of N-trifluoroacetyl adriamycin-14-valerate (AD32) on nuclear RNA synthesis in cultured L1210 cells.
    Wilson RG; King M; Lockwood R; McNeil M
    Chem Biol Interact; 1980 Nov; 32(3):331-7. PubMed ID: 7428121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of DNA degradation in vivo by adriamycin.
    Lee YC; Byfield JE
    J Natl Cancer Inst; 1976 Jul; 57(1):221-4. PubMed ID: 1003504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin transport and sensitivity in fatty acid-modified leukemia cells.
    Burns CP; North JA
    Biochim Biophys Acta; 1986 Aug; 888(1):10-7. PubMed ID: 3741885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
    Forssen EA; Tökès ZA
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1873-7. PubMed ID: 6940195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of adriamycin and N-trifluoroacetyladriamycin-14-valerate on cell kinetics, chromosomal damage, and macromolecular synthesis in vitro.
    Krishan A; Dutt K; Israel M; Ganapathi R
    Cancer Res; 1981 Jul; 41(7):2745-50. PubMed ID: 6972801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.